Publicaciones en colaboración con investigadores/as de Hospital de Sabadell (30)

2016

  1. Expert opinion on first-line therapy in the treatment of castration-resistant prostate cancer

    Critical Reviews in Oncology/Hematology, Vol. 100, pp. 127-136

  2. Phenotype and genotype in 52 patients with Rubinstein–Taybi syndrome caused by EP300 mutations

    American Journal of Medical Genetics, Part A, Vol. 170, Núm. 12, pp. 3069-3082